Midgard Science

Forge Biologics

Grove City, OH, United States forgebiologics.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Forge Biologics is a US-based gene therapy CDMO focused on AAV development and manufacturing. It supports researchers, foundations, biotech companies, and pharmaceutical companies from early development through clinical and commercial production, with operations centered in Columbus, Ohio.

Services

  • Research-grade AAV production (Blaze)

    Produces research-grade AAV material at 1–40L for proof-of-concept studies and vector manufacturability assessment.

  • AAV process development

    Develops product-specific AAV processes to improve yield, purity, efficiency, and cGMP readiness across natural and novel serotypes.

  • cGMP AAV manufacturing

    Manufactures AAV material for first-in-human, early clinical, pivotal clinical supply, and PPQ-related programs.

    CDMO: development & manufacturing

  • Late-phase cGMP manufacturing

    Supports pivotal studies and commercialization with process characterization, PPQ readiness, and BLA readiness.

    CDMO: development & manufacturing

  • Analytical development

    Develops and runs in-house analytical methods and assays for characterization and release.

  • Quality services

    Provides quality support integrated with manufacturing, including release-related and quality organization support.

  • Fill-finish

    Offers fill-finish support as part of integrated AAV manufacturing services.

    CDMO: development & manufacturing

  • Stability testing

    Provides stability testing for AAV programs.

5 more services
  • Molecular development consulting
  • Regulatory support
  • In-house plasmid production
  • Tech transfer
  • Toxicology material manufacturing

Capabilities

Assays and studies
  • AAV
  • Process development
  • Fill-finish
  • Analytical development
  • Bioreactors
  • Toxicology
6 more
  • Stability studies
  • HEK293
  • NGS
  • Potency
  • rcAAV
  • Release assays
Scale and capacity
  • 1–40L
  • 50–1,000L
  • 50–5,000L
  • 20 cGMP suites
  • 200,000+ sq. ft. cGMP facility
Therapeutic areas
  • Gene therapy
  • Retinitis pigmentosa
  • Hearing loss
  • Ultra-rare neurodegenerative genetic disease
  • AAV programs

Instruments and platforms

  • Single-use technologies
  • Closed-system processes

Modalities and species

Modalities
  • Viral vector
  • Plasmid DNA
Species and models
  • HEK293 suspension
  • Suspension HEK293 Ignition Cells
  • Master Cell Bank
  • Working Cell Bank

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: cGMP

Details

Type
CRDMO
Team
Over 450 experts
Based in
Grove City, OH, United States
Sites
Columbus, United States
Serves
Japan, Asia-Pacific

Similar labs